Skip to main content

Table 2 The effect on splicing determined by mini-gene assays and an overview of the mutations listed in the literature

From: Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients

Gene

IVS

Mutation

Frequency in the ESP database (Eur. Am.)

Mini-gene assay

Described in the literature

Classification

MLH1

1

c.117-34A > T

NI

No effect on splicing

Novel

Neutral

 

7

c.588 + 5G > A

NI

Out-of-frame skipping of exon 7

Pagenstecher; partial deletion of exon 7 [17]

Pathogenic

Tournier; deletion of exon 7 and exons 7–8 [15]

8

c.677 + 3A > T

NI

Out-of-frame skipping of exon 8

Novel

Pathogenic

11

c.1039-8 T > A

NI

No effect on splicing

Betz; No effect on splicing [16]

Neutral

15

c.1732-2A > T

NI

In-frame skipping of exon 16

Jäger* [5]

Pathogenic

Nilbert* [7]

Wijnen* [20]

MSH2

7

c.1276 + 1G > T

NI

In-frame exclusion of 48 bp of exon 7

Mangold* [21]

Pathogenic

10

c.1662-2A > C

NI

Out-of-frame skipping of exon 11

Novel

Pathogenic

14

c.2459-18delT

NI

No effect on splicing

Novel

Neutral

MSH6

5

c.3439-16C > T

0.43%

No effect on splicing

Perez-Cabornero* [22]

Neutral

Pinto* [23]

Sanchez de Abajo* [24]

  1. *The authors describe the mutation of interest, but do not examine its putative pathogenic effect. IVS = intron; NI = not identified.